Related Experiment Video
Updated: Jul 16, 2026

Scanning Skeletal Remains for Bone Mineral Density in Forensic Contexts
Published on: January 29, 2018
The relationship between birth weight leptin and bone mineral status in newborn infants
Mustafa Akcakus1, Selim Kurtoglu, Esad Koklu
1Department of Pediatrics, School of Medicine, Erciyes University, Kayseri, Turkey. akcakus@erciyes.edu.tr
Insights
Leptin levels in newborns did not correlate with bone mineralization, despite differences in birth weight. This study suggests leptin may not be a major regulator of fetal bone development.
Area of Science:
- Neonatal development
- Endocrinology
- Pediatric bone health
Background:
- Leptin is linked to fat and bone mass in fetal development.
- Umbilical venous leptin levels predict neonatal skeletal size and bone mineral density.
Purpose of the Study:
- To examine the correlation between birth weight, bone mineralization, and leptin levels in newborns.
- To assess the predictive value of anthropometrics and gender on bone mineral status.
Main Methods:
- 100 term newborns were analyzed, categorized by birth weight: appropriate for gestational age (AGA), small for gestational age (SGA), and large for gestational age (LGA).
- Umbilical cord venous blood samples were collected for leptin level measurement.
- Whole body bone mineral density and content were assessed using dual-energy X-ray absorptiometry within 24 hours of birth.
Main Results:
- Leptin concentrations were significantly higher in LGA and lower in SGA infants compared to AGA.
- LGA infants exhibited higher whole body bone mineral density and content, while SGA infants showed lower values.
- Regression analysis indicated no significant relationship between leptin levels and bone indices.
Conclusions:
- The study found no evidence to support leptin's major role in regulating bone metabolism in the developing neonatal skeleton.
- Findings suggest other factors may be more critical for bone development regulation in newborns.
Background:
The positive relationship between fat mass, bone mass and leptin has been shown in fetal mouse cartilage/bone. It has been shown that umbilical venous leptin predicts both the size of the neonatal skeleton and its estimated volumetric mineral density.
Aims:
This study investigates how birth weight and bone mineralization correlate with leptin levels. In addition, we aimed to determine the predictive value of anthropometrics measurements and gender on variability in bone mineral status.
Methods:
Umbilical cord venous blood samples were obtained at the delivery from 100 term newborn infants. Forty of the newborn infants had birth weights appropriate for gestational age (AGA), 30 were small for gestational age (SGA) and 30 were large for gestational age (LGA). Data were acquired using the whole body dual energy X-ray obsorptiometry scanner in the first 24 h after birth.
Results:
Leptin concentrations were higher in LGA (36.6 +/-12.0 ng/ml; p < 0.0001), but lower in SGA (11.7 +/- 5.6 ng/ml; p < 0.001) than in AGA infants (20.3 +/- 7.6 ng/ml). Whole body bone mineral density and whole body bone mineral content were higher in LGA babies (0.442 +/- 0.025 g/cm(2), 71.6 +/- 9.0 g, p < 0.01, p < 0.001, respectively) but lower in SGA (0.381 +/- 0.027 g/cm(2), 29.1 +/- 9.1 g, p < 0.001, p < 0.001, respectively) than in AGA babies (0.426 +/- 0.022 g/cm(2), 53.7 +/- 9.6 g, respectively). The percentage of whole body bone mineral content was lower in SGA (1.3 +/- 0.3) than in AGA (1.6 +/- 0.2, p < 0.001) and LGA (1.7 +/- 0.2, p < 0.001). In stepwise linear regression analyses models; leptin is not found related to the bone indices.
Conclusion:
Our study does not provide support for the hypothesis that leptin may play a major role in the regulation of bone metabolism in the developing skeleton.
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Bone Disorders
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Nature and Nurture
Regression Toward the Mean
Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug Dosing: Obese Patients
